PPT-Understanding Barriers To Cervical Cancer Screening And HPV Vaccination Among Refugee

Selemawit Ghebrendrias 1 Sarah Pfeil 1 Sheila K Mody 1 Bonnie Crouthamel 1 Morgen Chalmiers 1 Gennifer Kully 1 1 Division Of Family Planning Department Of Obstetrics Gynecology And Reproductive Sciences University Of California San Diego. . KrisEmily. . McCrory. , MD. Objectives:. Review cervical cancer epidemiology and . pathophysiology. Identify the role of the Human . Papilloma. Virus in cervical cancer. Explain the use of HPV testing in cervical cancer screening. Based on 2012 Guidelines & Recommendations. Sarah Lamanuzzi, MD, FAAFP. Disclosures. I have no disclosures other than: the ASCCP gave permission for use of their slide content.. The American Society for Colposcopy and Cervical Pathology. “Cervical Cancer Screening Recommendations, . Based on the 2012 Recommendations (ASCCP). Sarah Lamanuzzi, MD, FAAFP. Disclosures. I have no disclosures other than: the ASCCP gave permission for use of their slide content.. The American Society for Colposcopy and Cervical Pathology. “Cervical Cancer Screening Recommendations, . Review of . New Screening and Management Guidelines . Sarah Feldman MD MPH. Co-Director Ambulatory Gynecologic Oncology. Brigham & Women. ’. s Hospital . Dana Farber Cancer Institute. Lowell Cancer Center. . . Rebecca B. Perkins MD MSc. Associate Professor of Obstetrics and Gynecology. Boston University School of Medicine/ Boston Medical Center. 11/. 6. /15. Presenter Disclosure Information. Rebecca Perkins. . Rebecca B. Perkins MD, MSc. Assistant Professor of Obstetrics and Gynecology. Boston University School of Medicine/ Boston Medical Center. September 16. th. 2014. Adult Immunization Conference 2014. 141. st. APHA Annual Meeting. November 2013. Richard A. Crosby, PhD. University of Kentucky College of Public Health. Department of Health Behavior. . Presenter Disclosures. (1) The following personal financial relationships with commercial interests relevant to this presentation existed during the past 12 months:. Carolann Risley, MSN, WHNP, Kim Geisinger, MD. University of Mississippi Medical center. Purpose. Describe the number of women under 21 who were diagnosed with premalignant cervical cancer and correlate their history of vaccination.. Prepared by : . Khalid . Aldossari. Fahad. . Alshehri. Ali Al-Mater. Supervised by : Dr. ELSHEIKH. Out lines :. WHO principles for screening tests .. HPV ( . infection , prevention , vaccination . U.S. Department of Health & Human Services b after an abnormal test result.” “My doctor explained that cervical changes in cervical cells that are not cancer and can be treated. This was re CERVICAL CANCER. 4th most common cancer in women worldwide. CERVICAL CANCER. 4th most common cancer in women worldwide. >250,000 deaths/year. CERVICAL CANCER. 4th most common cancer in women worldwide. CSEB, June 10, 2016. Jason Lacombe. 1. , . Saima . Memon. 1. , Cindy Gauvreau. 1. ,. Cathy . Popadiuk. 2. , William Flanagan. 3. , Claude Nadeau. 3. , Andrew J. Coldman. 1. , Michael C. Wolfson. . 4. . Kelly S, Mc Fadden SL. School of Life and Health Sciences, University of Ulster . Jordanstown. . Introduction. Aim. Methodology. The aetiological factors associated with cervical cancer are relatively unknown, however scientific evidence links persistent infection with human papilomavirus (HPV) and the development of cervical carcinomas. . (Preliminary Results). Hawa Camara. |. November 17. th. , 2018. Facts about Cervical cancer in PNG. 2. Experiences of PoC HPV-DNA cervical screening in PNG. Need for improved screening services. 3.